| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Chief Comm & Corp Aff Officer | Common Stock | 131,378 | $18,333,799 | $139.55 | 27 Feb 2026 | Direct |
| GILEAD SCIENCES, INC. | Chief Comm & Corp Aff Officer | Restricted Stock Unit | 27,674 | $4,594,984 | $117.21 | 10 Dec 2025 | Direct |
| NEUROCRINE BIOSCIENCES INC | Director | Common Stock | 3,535 | $373,861 | $105.76 | 22 May 2025 | Direct |
| NEUROCRINE BIOSCIENCES INC | Director | Non-Qualified Stock Option | 2,982 | $219,475 | $73.60 | 22 May 2024 | Direct |
| NEUROCRINE BIOSCIENCES INC | Director | Restricted Stock Unit | 1,435 | $203,629 | $141.90 | 22 May 2024 | Direct |
| Arcus Biosciences, Inc. | Director | Common Stock | 0 | $0 | $21.00 | 29 Jan 2024 | Direct |
| GILEAD SCIENCES, INC. | Chief Comm & Corp Aff Officer | Non-qualified Stock Option (Right to Buy) | 48,110 | 17 Feb 2026 | Direct | ||
| NEUROCRINE BIOSCIENCES INC | Director | Restricted Stock Unit | 0 | 22 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES, INC. | 27 Feb 2026 | 1 | $0 | 4 | Chief Comm & Corp Aff Officer | 02 Mar 2026, 16:54 |
| GILD | GILEAD SCIENCES, INC. | 17 Feb 2026 | 5 | -$2,658,228 | 4 | Chief Comm & Corp Aff Officer | 18 Feb 2026, 17:22 |
| GILD | GILEAD SCIENCES, INC. | 03 Feb 2026 | 2 | -$3,553,344 | 4 | Chief Comm & Corp Aff Officer | 05 Feb 2026, 18:51 |
| GILD | GILEAD SCIENCES, INC. | 15 Jan 2026 | 1 | -$372,930 | 4 | Chief Commercial Officer | 16 Jan 2026, 18:10 |
| GILD | GILEAD SCIENCES, INC. | 15 Dec 2025 | 1 | -$366,000 | 4 | Chief Commercial Officer | 16 Dec 2025, 18:12 |
| GILD | GILEAD SCIENCES, INC. | 10 Dec 2025 | 3 | -$220,111 | 4 | Chief Commercial Officer | 11 Dec 2025, 18:25 |
| GILD | GILEAD SCIENCES, INC. | 17 Nov 2025 | 4 | -$1,858,173 | 4 | Chief Commercial Officer | 18 Nov 2025, 18:51 |
| GILD | GILEAD SCIENCES, INC. | 15 Oct 2025 | 1 | -$354,240 | 4 | Chief Commercial Officer | 16 Oct 2025, 21:28 |
| GILD | GILEAD SCIENCES, INC. | 15 Sep 2025 | 1 | -$340,710 | 4 | Chief Commercial Officer | 16 Sep 2025, 17:16 |
| GILD | GILEAD SCIENCES, INC. | 10 Sep 2025 | 3 | -$209,640 | 4 | Chief Commercial Officer | 11 Sep 2025, 18:31 |
| GILD | GILEAD SCIENCES, INC. | 15 Aug 2025 | 14 | -$1,652,927 | 4 | Chief Commercial Officer | 18 Aug 2025, 20:56 |
| GILD | GILEAD SCIENCES, INC. | 15 Jul 2025 | 1 | -$333,090 | 4 | Chief Commercial Officer | 16 Jul 2025, 17:45 |
| GILD | GILEAD SCIENCES, INC. | 16 Jun 2025 | 1 | -$330,510 | 4 | Chief Commercial Officer | 17 Jun 2025, 18:04 |
| GILD | GILEAD SCIENCES, INC. | 10 Jun 2025 | 3 | -$201,134 | 4 | Chief Commercial Officer | 11 Jun 2025, 18:58 |
| GILD | GILEAD SCIENCES, INC. | 22 May 2025 | 7 | -$1,344,564 | 4 | Chief Commercial Officer | 23 May 2025, 15:16 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 21 May 2025 | 3 | $0 | 4 | Director | 22 May 2025, 17:12 |
| GILD | GILEAD SCIENCES, INC. | 10 Mar 2025 | 5 | -$457,939 | 4 | Chief Commercial Officer | 12 Mar 2025, 19:15 |
| GILD | GILEAD SCIENCES, INC. | 04 Feb 2025 | 3 | -$4,474,811 | 4 | Chief Commercial Officer | 06 Feb 2025, 16:14 |
| GILD | GILEAD SCIENCES, INC. | 10 Dec 2024 | 3 | -$160,579 | 4 | Chief Commercial Officer | 11 Dec 2024, 19:08 |
| GILD | GILEAD SCIENCES, INC. | 06 Nov 2024 | 1 | -$456,400 | 4 | Chief Commercial Officer | 07 Nov 2024, 16:38 |
| GILD | GILEAD SCIENCES, INC. | 12 Sep 2024 | 2 | -$2,459,577 | 4 | Chief Commercial Officer | 13 Sep 2024, 17:08 |
| GILD | GILEAD SCIENCES, INC. | 10 Sep 2024 | 3 | -$141,217 | 4 | Chief Commercial Officer | 11 Sep 2024, 19:23 |
| GILD | GILEAD SCIENCES, INC. | 28 Aug 2024 | 1 | -$742,299 | 4 | Chief Commercial Officer | 29 Aug 2024, 15:23 |
| GILD | GILEAD SCIENCES, INC. | 13 Aug 2024 | 1 | -$406,150 | 4 | Chief Commercial Officer | 14 Aug 2024, 14:23 |
| GILD | GILEAD SCIENCES, INC. | 10 Jun 2024 | 3 | -$111,838 | 4 | Chief Commercial Officer | 11 Jun 2024, 19:18 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 22 May 2024 | 2 | $0 | 4 | Director | 23 May 2024, 17:59 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 17 May 2024 | 2 | $0 | 4 | Director | 21 May 2024, 16:46 |
| GILD | GILEAD SCIENCES, INC. | 10 Mar 2024 | 7 | -$342,472 | 4 | Chief Commercial Officer | 11 Mar 2024, 21:03 |
| GILD | GILEAD SCIENCES, INC. | 31 Jan 2024 | 3 | -$1,761,554 | 4 | Chief Commercial Officer | 02 Feb 2024, 14:34 |
| RCUS | Arcus Biosciences, Inc. | 29 Jan 2024 | 0 | $0 | 3 | Director | 07 Feb 2024, 18:58 |
| GILD | GILEAD SCIENCES, INC. | 09 Jan 2024 | 1 | -$702,466 | 4 | Chief Commercial Officer | 10 Jan 2024, 15:58 |
| GILD | GILEAD SCIENCES, INC. | 10 Dec 2023 | 3 | -$98,538 | 4 | Chief Commercial Officer | 11 Dec 2023, 19:15 |
| GILD | GILEAD SCIENCES, INC. | 10 Sep 2023 | 3 | -$95,456 | 4 | Chief Commercial Officer | 11 Sep 2023, 20:44 |
| GILD | GILEAD SCIENCES, INC. | 24 Jul 2023 | 3 | -$246,493 | 4 | Chief Commercial Officer | 25 Jul 2023, 18:15 |
| GILD | GILEAD SCIENCES, INC. | 10 Jun 2023 | 3 | -$99,369 | 4 | Chief Commercial Officer | 12 Jun 2023, 16:39 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 17 May 2023 | 2 | $0 | 4 | Director | 19 May 2023, 17:16 |
| GILD | GILEAD SCIENCES, INC. | 10 Mar 2023 | 7 | -$406,722 | 4 | Chief Commercial Officer | 13 Mar 2023, 21:00 |
| GILD | GILEAD SCIENCES, INC. | 24 Jan 2023 | 3 | -$1,287,606 | 4 | Chief Commercial Officer | 26 Jan 2023, 14:48 |
| GILD | GILEAD SCIENCES, INC. | 10 Dec 2022 | 3 | -$40,730 | 4 | Chief Commercial Officer | 13 Dec 2022, 14:12 |
| GILD | GILEAD SCIENCES, INC. | 10 Sep 2022 | 3 | -$29,898 | 4 | Chief Commercial Officer | 12 Sep 2022, 16:08 |
| GILD | GILEAD SCIENCES, INC. | 24 Jul 2022 | 3 | -$194,925 | 4 | Chief Commercial Officer | 26 Jul 2022, 12:31 |
| GILD | GILEAD SCIENCES, INC. | 10 Jun 2022 | 3 | -$28,062 | 4 | Chief Commercial Officer | 13 Jun 2022, 20:08 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 18 May 2022 | 1 | $0 | 4 | Director | 20 May 2022, 16:04 |
| GILD | GILEAD SCIENCES, INC. | 10 Mar 2022 | 7 | -$186,560 | 4 | Chief Commercial Officer | 14 Mar 2022, 21:14 |
| GILD | GILEAD SCIENCES INC | 26 Jan 2022 | 1 | $0 | 4 | Chief Commercial Officer | 28 Jan 2022, 19:53 |
| GILD | GILEAD SCIENCES INC | 24 Jul 2021 | 3 | -$236,394 | 4 | Chief Commercial Officer | 27 Jul 2021, 16:49 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 19 May 2021 | 1 | $0 | 4 | Director | 20 May 2021, 16:06 |